Thrombolytic Therapy

Subscribe to Selected New Research on Thrombolytic Therapy

5399 relevant articles (417 outcomes, 732 trials/studies) found for this Therapy

Description: Use of infusions of fibrinolytic agents to destroy or dissolve thrombi in blood vessels or bypass grafts.

Also Known As:

Therapeutic Thrombolysis; Therapy, Fibrinolytic; Therapy, Thrombolytic; Fibrinolytic Therapies; Therapeutic Thrombolyses; Therapies, Fibrinolytic; Therapies, Thrombolytic; Thrombolyses, Therapeutic; Thrombolytic Therapies; Fibrinolytic Therapy; Thrombolysis, Therapeutic

Relationship Network

Therapy Context: Research Results

Therapeutics: 5195

Drug Therapy: 116609

Thrombolytic Therapy: 5399

Hirudin Therapy: 7

Experts

1.	Gibson, C Michael: 15 articles (05/2008 - 10/2002)
2.	Cannon, Christopher P: 14 articles (05/2008 - 10/2002)
3.	Murphy, Sabina A: 13 articles (04/2008 - 10/2002)
4.	Antman, Elliott M: 13 articles (09/2007 - 10/2002)
5.	Braunwald, Eugene: 11 articles (05/2008 - 10/2002)
6.	White, Harvey D: 9 articles (01/2008 - 07/2002)
7.	Giugliano, Robert P: 9 articles (09/2007 - 09/2004)
8.	Sabatine, Marc S: 7 articles (05/2008 - 01/2005)
9.	Schellinger, Peter D: 7 articles (01/2008 - 02/2003)
10.	Topol, Eric J: 7 articles (01/2006 - 09/2002)

Related Diseases

1.	Myocardial Infarction 02/01/2008 - "BACKGROUND: Although primary coronary angioplasty seems to be the best treatment in acute myocardial infarction (MI), thrombolytic therapy still remains the most common reperfusion strategy particularly in smaller centers" 05/25/2005 - "This article examines thrombolytic therapy, the first-line treatment for patients presenting with acute myocardial infarction in most UK hospitals" 06/01/1996 - "CONCLUSIONS: These observational data, if replicated, suggest that in patients with acute myocardial infarction, thrombolytic therapy may be most effective in current smokers, whereas nonsmokers and ex-smokers may require other management strategies, such as emergency percutaneous transluminal coronary angioplasty." 12/01/1994 - "Thrombolytic therapy has been proven to be highly effective and safe in patients presenting with acute myocardial infarction" 07/15/1994 - "CONCLUSIONS: RV involvement during acute inferior myocardial infarction, accurately diagnosed by ST-segment elevation in V4R, is a strong, independent parameter for mortality and major in-hospital complications and may help to identify patients who will benefit most from thrombolytic therapy" Get all the results and reference details, order at left...
2.	Stroke (Strokes) 01/01/1993 - "CONCLUSIONS: Emergency cerebral angiography, which can be carried out relatively safely, adds important information about the nature and extent of the arterial occlusions, and the recanalization efficacy of fibrinolytic therapy for patients with acute stroke" 05/01/2008 - "BACKGROUND AND PURPOSE: Results of our recent pilot clinical trial suggest that the efficacy of thrombolytic therapy in acute ischemic stroke may be enhanced by the coadministration of high-dose albumin" 09/01/2003 - "RESULTS: Helicopter transport of acute stroke patients to tertiary care centers for thrombolytic therapy costs $35,000 per additional good outcome and $3,700 per QALY for the reference case" 01/01/2003 - "For patients treated within three hours of stroke, thrombolytic therapy appeared more effective in reducing death or dependency (OR 0.66, 95% CI 0.53 to 0.83) with no statistically significant adverse effect on death (OR 1.13, 95% CI 0.86 to 1.48)" 05/01/2000 - "This strategy is associated with a significant reduction in the incidence of reinfarction and the combined clinical end-point of death/reinfarction/stroke at 30 days when compared to standard thrombolytic therapy at the community hospital." Get all the results and reference details, order at left...
3.	Thrombosis (Thrombus) 09/16/2008 - "The optimal management of the right heart thromboemboli remains unclear, but thrombolytic therapy with rt-PA appears to be rapidly effective in most patients resulting with complete resolution of the thrombus and improvement of pulmonary perfusion" 01/01/2005 - "Consensus on optimal treatment continues to be hampered by a lack of randomized trials, but recent studies demonstrate the efficacy of thrombolytic therapy in acute thrombosis, and the apparent safety and benefit of anticoagulation in patients with chronic portal vein thrombosis." 01/01/1994 - "The paper reports a case of a positive response to fibrinolytic therapy with complete lysis of the thrombus in the left internal carotid artery (ICA) and significant reduction of the baseline neurological deficiency" 04/01/2002 - "We report the successful management of acute portal vein thrombosis with percutaneous transphepatic thrombolytic therapy" 02/01/1994 - "Local thrombolytic therapy may be beneficial for other patients with rapid neurologic deterioration caused by extensive thrombosis of superficial and deep venous structures." Get all the results and reference details, order at left...
4.	Pulmonary Embolism 09/01/1998 - "This case suggests that delayed thrombolytic therapy in patients with massive pulmonary embolism can still be beneficial in selected cases, even if given more than 2 weeks after symptom onset." 06/01/1996 - "We found a significant ABD-assisted right ventricular hypokinetic regression after thrombolytic therapy in acute pulmonary embolism but could not demonstrate a linear relation between improvement in early right ventricular function and angiography." 06/01/1989 - "Many investigators have reported about beneficial results with thrombolytic therapy in patients with acute pulmonary embolism" 04/15/1992 - "OBJECTIVES: To determine whether thrombolytic therapy reduces the rate of death or complications in patients with acute pulmonary embolism and whether a particular thrombolytic regimen is more effective than others" 03/15/2002 - "Is thrombolytic therapy effective for pulmonary embolism?" Get all the results and reference details, order at left...
5.	Hemorrhage 12/19/1996 - "Despite the fact that each of the third-generation drugs has shown considerable potential with regard to improving the efficacy of thrombolytic therapy, the risk of intracranial bleeding remains problematic and will need to be assessed in large, randomized trials." 09/01/1994 - "Although safe and effective, thrombolytic therapy is relatively contraindicated within 10 days of major surgery due to the risk of bleeding" 11/19/1988 - "Our experience confirms the reduced incidence of allergic side effects (3.5%), major bleeding (0.3%) and minor bleeding (2.9%) during or after thrombolytic therapy." 12/01/2003 - "However, primary percutaneous coronary intervention (PCI) is associated with improved outcomes and less bleeding complications compared with fibrinolytic therapy, but it is not widely available" 12/01/1993 - "All 3 trials have shown that immediate PTCA does not affect positively, but can worsen, the outcome of thrombolytic therapy since it increases mortality and bleeding complication with no improvement in reocclusion rate" Get all the results and reference details, order at left...
325 Diseases and 5399 more articles analyzed in the Research Interface, order at left...

Related Drugs and Biologics

1.	Tissue Plasminogen Activator (Alteplase)
2.	Streptokinase
3.	Urinary Plasminogen Activator (Urokinase)
4.	Heparin (Liquaemin)
5.	Aspirin (Acetylsalicylic Acid)
6.	Fibrinolytic Agents (Antithrombotic Agents)
7.	glucuronyl glucosamine glycan sulfate (Vessel)
8.	Fibrin
9.	Plasminogen Activators (Plasminogen Activator)
10.	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)
315 Drugs and Important Bio-Agents and 1255 more articles analyzed in the Research Interface, order at left...

Related Therapies and Procedures

1.	Angioplasty (Angioplasties)
2.	Percutaneous Coronary Transluminal Angioplasty (PTCA)
3.	Transplants (Transplant)
4.	Coronary Artery Bypass (Coronary Artery Bypass Surgery)
5.	Cardiopulmonary Resuscitation (CPR)
89 Therapies and Procedures and 714 more articles analyzed in the Research Interface, order at left...

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License details >>

Price:

$490.00 access via web interface, 1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m", 1 year subscription

Proceed to Checkout >>